Equities

Hokkaido Shika Sangyo Co Ltd

7693:TYO

Hokkaido Shika Sangyo Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (JPY)105.00
  • Today's Change0.00 / 0.00%
  • Shares traded--
  • 1 Year change--
  • Beta--
Data delayed at least 20 minutes, as of Nov 16 2020.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Hokkaido Shika Sangyo Co Ltd is a Japan-based company mainly engaged in the wholesale of dental instruments and materials. The Company is involved in the wholesale business of dental instruments and dental materials to dental clinics and dental laboratories in Hokkaido, the repair and maintenance business of dental equipment, the lecture business on dentistry, the opening and closing support business of dental. The main products include dental materials such as sharpened tooth prostheses and chemicals; dental instruments such as dental units, dental digital X-ray machines; oral care products such as toothbrushes and dentifrices, prevention related lectures on dentistry and others; repair and maintenance of dental equipment and dental metals.

  • Revenue in JPY (TTM)4.85bn
  • Net income in JPY63.72m
  • Incorporated1952
  • Employees56.00
  • Location
    Hokkaido Shika Sangyo Co Ltd4-36-77Kikusuikami-machi Nijo, Shiroishi-kuSAPPORO-SHI 003-0812JapanJPN
  • Phone+81 118135556
  • Fax+81 118135680
  • Websitehttps://hokusan-kk.co.jp/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Hokkaido Shika Sangyo Co Ltd4.85bn63.72m647.30m56.00----11.880.133413.2713.271,010.95144.883.8328.3010.0186,653,230.005.031.888.743.2715.5114.601.310.50651.58--0.085.004.922.4994.6821.0730.45--
AJJ Medtech Holdings Ltd282.42m-295.87m691.03m----15.90--2.45-0.0025-0.00250.00230.00030.58081.581.79---60.84-27.83-181.33-35.1833.58---104.76-346.420.5438-43.550.7796--170.9716.9630.94------
Pasture Holdings Ltd2.18bn86.47m743.48m--8.591.105.620.34180.00570.00570.14340.04471.403.5820.73--5.55--11.26--24.65--3.97--1.009.240.3202--44.92--143.07------
Adherium Ltd228.54m-1.02bn756.59m----1.13--3.31-0.0275-0.02750.00620.00890.20311.051.22---90.61-110.82-129.82-157.5635.3349.25-446.19-413.922.43--0.0142---54.47-4.27-3.71---83.48--
Hetzer Medical Indonesia Tbk PT168.30m-20.32m760.53m24.00--1.3129.914.52-1.34-1.3411.0638.160.23510.64124.15720,355,100.00-2.84---3.18--59.04---12.07--1.48-2.710.0891---39.79---1,606.14------
Visioneering Technologies Inc1.34bn-537.18m768.49m----1.14--0.5755-0.122-0.1220.2950.12241.212.087.06---48.75-76.38-75.48-97.7056.7444.90-40.22-98.702.44--0.00--19.0121.3641.05------
Inhalerx Ltd88.93m-75.48m800.38m--------9.00-0.004-0.0040.0047-0.00031.05--2.81---88.94-80.34-252.07-99.88-----84.88-500.13---11.571.19--2,226.0922.7925.10------
Global Health Limited864.44m-130.87m810.56m49.00------0.9377-0.0226-0.02260.1493-0.052.80--11.81---42.35-34.67---112.4181.1878.53-15.14-32.95---12.78----10.869.4283.71---55.12--
Data as of Nov 16 2020. Currency figures normalised to Hokkaido Shika Sangyo Co Ltd's reporting currency: Japanese Yen JPY
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.